| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 612BYT76F3 |
| InChI Key | HYOGJHCDLQSAHX-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H25ClN2O |
| Molecular Weight | 344.89 |
| AlogP | 4.69 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 25.24 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 24.0 |
| Primary Target | |
|---|---|
| mGlu2 receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | - | - | - | 43-51 | |
|
Membrane receptor
Family C G protein-coupled receptor
Small molecule receptor (family C GPCR)
Neurotransmitter receptor (family C GPCR)
Metabotropic glutamate receptor
|
65-2570 | 68 | - | 180 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Schizophrenia | 2 | D012559 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Seizures | 2 | D012640 | ClinicalTrials |
| Perceptual Disorders | 1 | D010468 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1127498-03-6 |
| ChEMBL | CHEMBL3337527 |
| DrugBank | DB12059 |
| FDA SRS | 612BYT76F3 |
| Guide to Pharmacology | 8946 |
| PDB | HZR |
| PubChem | 25195461 |
| SureChEMBL | SCHEMBL1035416 |
| ZINC | ZINC000059047060 |